Sept 16 (Reuters) - Britain's FTSE 100 index is seen opening 16 points lower at 6,089 on Wednesday, according to financial bookmakers. * AstraZeneca: The U.S. Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was working with the company to figure out if there was a significant safety issue or not. * PREMIER OIL: Premier Oil Plc said on Tuesday it was in talks with private-equity backed oil producer Chrysaor and several other parties on alternative deals to secure long-term debt refinancing. * GOLD: Gold prices held steady on Wednesday as investors awaited the outcome of the U.S. Federal Reserve's policy meeting, hoping for details of the central bank's plans to balance interest rates against its inflation target. * OIL: Oil prices rose on Wednesday, extending gains from the previous session, as a hurricane disrupted U.S. offshore oil and gas production and an industry report showed a big drop in U.S. crude stockpiles. * The UK blue-chip index closed 1.3% higher on Tuesday as miners were helped by upbeat Chinese industrial output data, while the mid-cap index was supported by insurers on the prospect of lower-than-expected COVID-19 payouts. * UK CORPORATE DIARY: Galliford Try Plc FY results Redde Northgate Plc FY results Pan African Resources FY results accesso Technology Group Plc HY results * For more on the factors affecting European stocks, please click on: TODAY'S UK PAPERS > Financial Times > Other business headlines (Reporting by Samantha Machado in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.